Warby Parker (WRBY) Change in Receivables (2020 - 2026)
Warby Parker's (WRBY) quarterly Change in Receivables came in at -$1.5 million in Q1 2026, down 220.84% YoY from $1.3 million in Q1 2025, and down 171.15% on a QoQ basis from $2.1 million in Q4 2025.
Warby Parker (WRBY) Change in Receivables (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Change in Receivables data on file, last reported at -$1.5 million in Q1 2026.
- Quarterly Change in Receivables fell 220.84% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288000.0 (down 5.88% YoY) and the FY2025 annual result came in at $1.3 million, up 691.12% from the prior year.
- Change in Receivables slipped to -$1.5 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.1 million in Q4 2025 to a low of -$1.5 million in Q1 2026.
- A 5-year average of $45764.7 and a median of $4000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 225.85% — and 2025, when it slumped 914.63%.
- Tracing WRBY's Change in Receivables over 5 years: stood at $325000.0 in 2022, then jumped by 225.85% to $1.1 million in 2023, then decreased by 19.26% to $855000.0 in 2024, then surged by 150.53% to $2.1 million in 2025, then plunged by 171.15% to -$1.5 million in 2026.
- The last three Change in Receivables figures came in at -$1.5 million (Q1 2026), $2.1 million (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 319,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 319,000.00 |
| Jun 30, 2026 | 319,000.00 |
| Mar 31, 2026 | -1.52 Mn |
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -334,000.00 |
| Jun 30, 2025 | -334,000.00 |
| Mar 31, 2025 | -475,000.00 |
| Mar 31, 2025 | -475,000.00 |
| Dec 31, 2024 | 855,000.00 |
| Dec 31, 2024 | 855,000.00 |
| Sep 30, 2024 | -115,000.00 |
| Sep 30, 2024 | -115,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | -612,000.00 |
| Mar 31, 2024 | -612,000.00 |